“Medical device industry executives often develop products that are deemed safe and effective by the FDA, but that do not sell as they are not reimbursable,” says Donald DeLauder, Executive Director - Corporate Innovation, Bayer Radiology and Interventional. They must spend more time on developing their products, he adds.
